A compounded preparation carries no FDA-assigned National Drug Code of its own, yet every claim a pharmacy submits for it still runs through adjudication systems built around eleven-digit NDC numbers. PBMs, Medicare, Medicaid, and TRICARE now reconcile that gap at the ingredient level, matching the NDCs on a claim to the pharmacy's own purchase invoices. Where ingredient-level billing does not match what the pharmacy actually bought and used, the audit finding gets written up as a billing integrity issue, not a compounding error.
No Independent NDC for Compounded Preparations
National Drug Codes are assigned to the manufacturer or labeler of a drug product under FDA's own numbering system, not to the pharmacy filling an individual prescription. Under the 503A/503B framework, a 503A pharmacy compounding from bulk active ingredient typically has no NDC to put on the claim at all. A 503B outsourcing facility, because it registers with FDA and operates under cGMP standards, may voluntarily assign an NDC to a finished compounded product, though nothing requires it to. Either way, the claim has to identify every ingredient the pharmacy actually used by that ingredient's own NDC, not by a placeholder or the NDC of a commercial product the compound merely resembles.
Ingredient-Level Billing Under NCPDP D.0
Under the NCPDP Telecommunication Standard, a compound claim carries a Product/Service ID of zero at the claim level, then a separate compound segment listing each ingredient by its own NDC, its metric quantity, and its ingredient cost. That structure replaced older shortcuts, billing the single most expensive ingredient's NDC for the whole claim, or entering a placeholder NDC such as 99999-9999-99, that most payors no longer accept. Every ingredient NDC on the claim has to be active and currently marketed; an NDC pulled from an old invoice, a discontinued package size, or a different strength than what the pharmacy actually compounded from will not adjudicate as billed, and it will not hold up once a PBM pulls the claim for audit.
What PBM and Payor Audits Find
PBM audit teams reconcile a pharmacy's dispensing history against its wholesaler purchase invoices at the NDC level, and a compound claim functions as several claims within one: every ingredient NDC has to trace back to a matching purchase in the right quantity and time frame. An ingredient billed that the invoices do not support, or a strength or package size that does not match what was purchased, gets treated as an unsupported claim and recouped in full rather than adjusted to the correct ingredient cost. Compounded GLP-1 preparations carry the same exposure, layered on top of a separate enforcement wave over semaglutide and tirzepatide ingredient sourcing.
Federal program audits reach the same problem with more consequence. A Middle Georgia compounding pharmacy paid $365,000 to resolve False Claims Act allegations that it billed Medicare, Medicaid, and TRICARE for compounded medications made with non-reimbursable bulk powders while billing as though reimbursable tablets had been used. An ingredient supplier separately paid $21.75 million to resolve allegations that it inflated the average wholesale price reported under two ingredient NDCs, pricing that fed directly into what pharmacies were reimbursed for compounds built from those ingredients.
A pharmacy is judged by the NDCs on the claim it filed, not by the compound it actually made.
Why Early Legal Counsel Is Critical
It is critical that compounding pharmacies promptly retain experienced healthcare defense counsel once a PBM audit notice or a government inquiry into compound billing arrives, rather than after a recoupment demand or subpoena follows. Early legal intervention can protect the pharmacy's rights, ensure ingredient-level documentation is reconstructed correctly before it goes to the auditor, preserve relevant defenses, and let counsel communicate with the PBM or investigator directly. Waiting until the finding becomes a network termination or a referral to the state board of pharmacy narrows what the response can still accomplish.
How Health Law Alliance Can Help
Health Law Alliance represents compounding pharmacies through PBM ingredient-billing audits, NDC-related recoupment demands, and the state board and federal inquiries that can follow, as part of the firm's compounding pharmacy defense practice. If your pharmacy is facing an audit finding built on NDC assignment or ingredient-level billing, contact us for a free, confidential consultation.
